Supplemental material
Expert Opinion on Drug Safety
Volume 20, 2021 - Issue 11
Original research
Comprehensive evaluation of post-approval regulatory actions during the drug lifecycle – a focus on benefits and risks
Lourens T. Bloema Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;b Pharmacovigilance department, Dutch Medicines Evaluation Board, Utrecht, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-0014-8625View further author information
https://orcid.org/0000-0002-0014-8625View further author information, , , , , & Aukje K. Mantel-Teeuwissea Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlandshttps://orcid.org/0000-0002-8782-0698View further author information
https://orcid.org/0000-0002-8782-0698View further author information show all